TIDMMIL
RNS Number : 8364G
Myanmar Investments Intl Ltd
30 November 2020
This announcement contains inside information 30 November
2020
Myanmar Investments International Limited
Audited financial results for the 18-month period to 30
September 2020
Myanmar Investments International Limited [AIM: MIL] ("MIL" or
the "Company"), the Myanmar focused investment company, today
announces its audited financial results for the 18-month period to
30 September 2020.
Copies of the Company's annual report and accounts will be sent
to shareholders and warrant holders shortly and will also be
available to download from the Company's website on
www.myanmarinvestments.com/financial-reports.
Highlight
During the 18-month financial period our net asset value ("NAV")
has increased by 6.0 per cent and was US$35.3 million as at 30
September 2020, equivalent to US$ 0.93 per share.
Future Strategy
In late 2018, the Directors felt that the investment environment
in Myanmar is unlikely to generate an appropriate risk adjusted
return commensurate with an investment in a frontier economy.
Accordingly, the Directors thought that it was appropriate to start
planning for an orderly disposal of our three investments with a
view to ultimately winding up the Company.
At last year's AGM, held in Yangon on 24 October 2019, the
shareholders approved a resolution to amend the Company's
Investment Policy such that the Board can:
-- undertake an orderly disposal of its investments; and
-- return surplus capital to shareholders.
Since then the Directors have taken the following action to
implement this new strategy:
-- We sold our investment in Medicare International Health &
Beauty ("Medicare") for US$1 million to our main joint venture
partner in November 2019. The transaction was completed in December
2019.
-- We are in the advanced stages of selling our investment in
Myanmar Finance International Limited ("MFIL") .
-- We have continued to streamline our operations and as a
result reduced our overheads. As part of the cost reduction
process, we closed our office in Yangon and removed staff costs
from this operation as of 31 March 2020.
Business review
The Company had invested in three businesses:
AP Towers Holdings Pte. Ltd ("AP Towers") / Apollo Towers
-- The Company had invested US$21 million in Apollo Towers.
-- Under the share swap (which was completed in January 2020),
the Company exchanged its indirect interest of 9.1 per cent of
Apollo Towers for an indirect interest of 4.1 per cent of AP
Towers.
-- The share swap effectively brought Apollo Towers and Pan Asia
Towers, another Myanmar independent tower company, under the common
ownership of AP Towers.
-- Future growth will be driven by an increase in the tower
portfolio and also by an increase in tenancies as co-location rates
rise.
-- As at 30 September 2020, Apollo Towers and Pan Asia Towers
together had an aggregated portfolio of 3,245 towers, 6,658 tenants
and a co-location ratio ("Lease-up-Rate" or "LUR") of 2.05x. This
compares to an LUR of 2.04x at 30 September 2019 and 2.05x at 31
March 2020.
-- As of 30 September 2020, AP Towers annualised adjusted "run
rate" revenue and EBITDA has increased to US$104.5 million and
US$83.4m, respectively. This represents an increase of 2.6 per cent
and 6.6 per cent, respectively over the same period last year.
-- AP Towers' net debt was US$429.3 million as at the end of
September 2020, an increase of US$ 57.7 million since 31 March
2020. The application of IFRS 16 caused an increase of net debt by
US$62.0 million. Excluding the effect of IFRS 16, net debt
decreased by US$ 4.3 million since 31 March 2020.
-- On 7 April 2020 APTH refinanced approximately $140m of
mezzanine debt that had originally been raised by Apollo. That has
resulted in a significant reduction in the cost of that borrowing
that will benefit shareholders going forward.
-- Contrary to other industries, the telecommunication sector
has not suffered greatly due to the outbreak of Covid-19.
Myanmar Finance International Limited ("MFIL")
-- MIL has invested US$2.7 million for a 37.5 per cent shareholding.
-- It is one of Myanmar's leading microfinance companies.
-- Strong growth in its borrower base and loan book at 30
September 2020 at 48,000 and US$17.5 million, representing compound
annual growth rates ("CAGR") of 42 per cent and 115 per cent
respectively since investment.
-- MFIL focuses on urban and semi-rural lending in Yangon, Bago, Ayewady and Mon State.
-- The Company is in the process of selling this investment. On
1 April 2020, the Company announced that it has accepted an offer
to sell its shareholding in MFIL subject to the purchaser's AGM
approving the purchase, lender's consent, and Myanmar regulatory
approval. Subsequent to that announcement, the purchaser's AGM on
23 April 2020 has approved the transaction and the lenders have
given their consent.
However, because of Covid-19 which, inter alia, has stopped all
commercial air travel between Myanmar and Thailand, little progress
has been made in obtaining regulatory approval. Assuming a level of
normalcy returns over the next few months we expect completion to
take place within the next 4 to 6 months.
However, there is no indicator of impairment on our investment
in MFIL, because the minimum consideration for this transaction
will be calculated based on a pre-agreed formula of 2 times the
audited book value of MFIL at closing once conditions have been
satisfied, according to the Binding Offer from the Purchaser.
-- Subsequent to our year end in late October 2020 MFIL's
regulator, the Financial Regulatory Department ("FRD"), directed
that all microfinance companies operating in Yangon, Bago and
Rakhine suspend all client repayments for 2 months. To assist the
industry all affected microfinance companies including MFIL were
provided with interest free loans to cover the uncollected amounts.
92 percent of MFIL's loan book is in Bago and Yangon.
Medicare
-- MIL had invested US$2.1 million for a 48.6 per cent shareholding.
-- Greenfield joint venture in pharmaceutical, health and beauty franchise retailing.
-- A joint venture with Medicare, Vietnam's leading pharmacy, health and beauty retail group.
-- Given the Company's strategy of looking to realise its
investments, coupled with Medicare's continued operating losses
that needed funding as well as the capex needed to get Medicare to
achieve critical mass, the Directors concluded that it was
preferable to exit from this investment sooner rather than
later.
-- As a result, the Company agreed with the owners of Medicare
Vietnam, its main joint venture partner, to sell this investment
for US$1 million in November 2019. This represented a loss of
US$1.1 million on the cost of the investment which largely reflects
MIL's share of the operating losses to date. The Company had booked
US$1.5 million as its share of results of this joint venture
(equity method). Therefore, the sales price of US$1 million
represents a gain on the disposal of this investment of US$0.4
million.
Financial review
During the past 18-month financial period our net asset value
("NAV") has increased by 6.0 per cent and was US$35.3 million as at
30 September 2020. This was driven mainly by the increase in the
assessed value of our investments in AP Towers (up US$4.3 million
to US$28.3 million).
During the period we drastically reduced our operating
"run-rate" costs from US$1.3 million per annum to the equivalent of
US$0.7 million per annum by year-end.
Henrik Bodenstab, Chairman of MIL, "We have implemented the
changes to our strategy as mandated by the shareholders last year.
We have sold our investment in Medicare and we are in advanced
stages to sell our investment in MFIL. In addition, our operating
costs have been reduced significantly to maximise the return of
surplus capital to our shareholders."
The information contained within this announcement is deemed to
constitute inside information as stipulated under the Market Abuse
Regulation (EU) No. 596/2014. Upon the publication of this
announcement, this inside information is now considered to be in
the public domain.
For further information please contact:
Nick Paris Michael Rudolf
Managing Director CFO
Myanmar Investments International Myanmar Investments International
Limited +95 (0) 1 387 947 Limited +95 (0) 1 387 947
nickparis@myanmarinvestments.com michaelrudolf@myanmarinvestments.com
Nominated Adviser Broker
Philip Secrett / Jamie Barklem William Marle / Giles Rolls
/ Seamus Fricker finnCap Ltd
Grant Thornton UK LLP +44 (0) 20 7220 0500
+44 (0) 20 7383 5100
For more information about MIL, please visit
www.myanmarinvestments.com
CHAIRME N'S LETTER
Dear fellow shareholder
MYANMAR: COVID-19 AND NOVEMBER ELECTIONS
Myanmar experienced its first Covid-19 case in late March 2020
and by early April the country went into its first lockdown. When
we published of our interim results on 29 June 2020 there were 299
positive cases and 6 deaths. The situation remained under control
and by mid-August the number of cases was only 374 with no increase
in deaths. Whereas Thailand and Singapore had seen the number of
cases increasing to over 3,500 and 55,000, respectively but
starting to level off.
However, since then there has been a significant increase. As at
20 November, the number of positive cases is more than 77,750 with
over 1,722 deaths. Yangon, accounts for three quarters of this
increase.
A second, and more stringent lockdown, has been in effect since
September. This has disrupted commerce and investments.
International air travel, apart from relief flights, in and out of
the country has been significantly reduced and border trade
disrupted. This is likely to continue, at least, until the new
year.
Against this backdrop, in September 2020, the Asian Development
Bank has forecast that GDP growth in 2020 will reduce to 1.8
percent. This compares favourably to Thailand or Singapore which
are forecast to shrink by 8.0 and 6.2 percent, respectively.
While the headline figure show a level of resilience, primarily
due to Myanmar being an exporter of much needed commodities such as
gas, rice, beans and pulses to neighbouring countries, it masks the
reality on the ground that many small businesses especially in the
hospitality and manufacturing sector have been severely affected
with layoffs and closures. In turn significantly impacting consumer
spending power.
However, the Directors do not see a significant impact on our
two investments. Contrary to other industries, the
telecommunication sector has not suffered greatly due to the
outbreak of Covid-19. Regarding MFIL there is no indicator of
impairment on our investment, because the minimum consideration for
selling this investment will be calculated based on a pre-agreed
formula of 2 times the audited book value of MFIL at closing once
conditions have been satisfied, according to the Binding Offer from
the Purchaser.
In the middle of the pandemic, on 8 November 2020, Myanmar held
a general election. The mood was subdued with few rallies and
limited canvassing because of the lockdown.
The house of Representatives has 440 members of which 110 (25%)
is appointed by the military. Out of 330 contested constituencies
Daw Aung San Suu Kyi's party, The National League for Democracy
("NLD") won 258 seats giving it an outright majority of 38. This is
an increase over the party's 255 seats in the 2015 election.
However, with its 25 percent, the military will continue to be able
to veto changes that are not to its liking.
With the same popular mandate Daw Aung San Suu Kyi is unlikely
to make significant changes to her policies.
A new government will be sworn in on 1 April 2021 and we wait to
see the composition of the new cabinet. Will there be new faces in
the line up? Will she be bolder? At 75 she is less likely to lead
the party into the 2025 general election and therefore will she
begin to broaden the party's executive committee and bring in
younger blood? Without her leadership will NLD hold together as one
unified party? All these questions will dictate Myanmar's progress
over the next five years.
BOARD CHANGES
William Knight our former Chairman who had held this position
since the Company's launch in 2013, retired on 18 August 2020
having reached the Company's compulsory retirement age.
The Board of Directors elected Henrik Bodenstab to become the
new Chairman who has been an independent non-executive Director of
the Company since 2016 .
Also, our former Managing Director, Craig Martin stepped down as
both Managing Director and a Director of the Company as of 31
October 2019 and Michael Dean, our former Finance Director, stepped
down as both Finance Director and a Director of the Company as of
31 October 2019.
On behalf of the Board, we should like to thank William, Craig
and Mike for their considerable contribution to the Company and its
shareholders.
Nick Paris, formerly a non-independent non-executive Director,
became Managing Director as of 1 November 2019 and Rudolf
Gildemeister joined the Board of Directors as an independent
non-executive Director as of 1 November 2019.
The Board of Directors would like to welcome Nick and Rudolf to
their new roles.
REPORTING PERIOD
As announced on 2 September 2019, to conform with the need to
change the Company's year-end to bring it in line with the new
Myanmar government mandated year end of 30 September the Company
issued 6-month interim accounts for the period to 30 September 2019
(announced on 28 November 2019) and 6-month interim accounts for
the period to 31 March 2020 (announced on 29 June 2020). Both sets
of interim accounts were reviewed by BDO LLP, the Company's
statutory auditors. Therefore, this report with a full audited set
of financial statements comprises the 18-month period from 1 April
2019 (the last full audited set of financial statements) to 30
September 2020.
CHANGE IN STRATEGY
At last year's Annual General Meeting (" AGM ") shareholders
approved a resolution to amend the investment objective and
policies of the Company as follows:
"The Company will seek to realise the Company's investments in
an orderly manner, such realisations to be effected at such times,
on such terms and in such manner as the Directors (in their
absolute discretion) may determine.
Following such realisations, the Company will make periodic
returns of surplus capital to Shareholders on such terms and in
such manner as the Directors (in their absolute discretion) may
determine.
The Company shall not make any new investments in projects to
which it is not already committed. However, this will not preclude
the Directors (in their absolute discretion) from: (a) authorising
the expenditure of such capital as is necessary to: (i) complete
arrangements pertaining to the Company's existing investments; or
(ii) carry out any activities that the Directors (in their absolute
discretion) deem appropriate to ensure the sale ability of any
existing investment; or (b) entering into any contract or other
arrangement with any third party to realise all or any part of the
Company's existing investments.
Following the disposal of all of the Company's existing
investments, the Directors intend to put a winding up proposal to
the Shareholders."
Important steps have been made to implement this new
strategy:
-- We sold our investment in Medicare International Health &
Beauty ("Medicare") for US$1 million to our main joint venture
partner in November 2019. The transaction was completed in December
2019. This represented a loss of US$1.1 million on the cost of the
investment which largely reflects our share of the operating losses
from opening a chain of new stores in Myanmar.
-- We are in the advanced stages of selling our investment in
Myanmar Finance International Limited ("MFIL") . On 1 April 2020 we
announced that we have accepted an offer to sell our shareholding
in MFIL to a Thai based company subject to the purchaser's AGM
approving the purchase, lender's consent, and Myanmar regulatory
approval. The minimum consideration for this transaction will be
calculated based on a pre-agreed formula of 2 times the audited
book value of MFIL at closing once these conditions have been
satisfied. Subsequent to that announcement, the purchaser's AGM on
23 April 2020 approved the transaction and the lenders to MFIL have
given their consent. However, because of Covid-19 which, inter
alia, has stopped all commercial air travel between Myanmar and
Thailand, obtaining regulatory approval for the transaction has
been delayed. We have agreed an extension to the transaction
closing with the buyer and expect to complete the transaction
within the next 4 to 6 months.
-- We have continued to streamline our operations and as a
result reduced our overheads with most of the reductions coming
towards the end of this reporting period. As part of the cost
reduction process, we closed our office in Yangon and laid-off our
local staff as of 31 March 2020. The annualised core cash-based
overheads for the 6-month period from 1 April 2020 to 30 September
2020 are 43 % lower than for the 12-month period from 1 April 2019
to 31 March 2020 and even 55 % lower than for the 12-month period
from 1 April 2018 to 31 March 2019.
We are now holding around US$2.4 million of cash and when the
sale of MFIL completes we will seek to return surplus capital to
our shareholders. We will also be able to streamline our operations
further as by then we will only have one investment left. We will
thereby continue to reduce our operating expenses.
Our investment in Apollo Towers was swapped for an interest in
AP Towers Holdings Pte Ltd ("AP Towers") in January 2020. Under
this share exchange, MIL's 66.6 per cent subsidiary, MIL 4 Limited
("MIL4") , exchanged its existing 13.7 per cent shareholding in
Apollo Towers for a shareholding of 6.2 per cent in AP Towers, of
which 4.1 per cent is attributable to MIL. The share exchange
effectively brought Apollo Towers and Pan Asia Towers, another
Myanmar ITC, under the common ownership of AP Towers which now
manages one of the largest network of towers in Myanmar. This
investment should not require additional funding. We also believe
that in due course the resultant investment in AP Towers can be
exited by way of a sale to a strategic investor or a listing on one
of the region's stock exchanges.
CORPORATE GOVERNANCE
The Company seeks to uphold the fundamental principles of good
corporate governance and has adopted the Quoted Companies Alliance
2018 Corporate Governance Code. The Chairman's Statement on
Corporate Governance provides greater detail on how the Board
itself operates as well as the steps taken to ensure that its staff
adhere to principles such as compliance with the UK anti-bribery
legislation.
On behalf of the Board, we should like to take this opportunity
to thank a number of our key stakeholders: our staff for their
professionalism and commitment; our business partners for all of
their advice and contributions; and our shareholders for their
continued support.
HENRIK BODENSTAB AUNG HTUN
Chairman
Deputy Chairman
27 November 2020 27 November 2020
EXECUTIVE DIRECTOR'S REVIEW
Business Review
During the past 18 months our net asset value ("NAV") has
increased by 6.0 per cent and was US$35.3 million as at 30
September 2020. This change is mainly attributable to the increase
in the assessed value of the Company's investments in AP Towers (up
US$4.3 million to US$28.3 million) which is offset by the loss on
disposing of our investment in Medicare (US$215,000) and the
operating expenses for the reporting period (US$2.1 million).
During the past 18 months we drastically reduced our operating
"run rate" costs from US$1.3 million per annum to the equivalent of
US$0.7 million per annum by the period-end.
Overall, our businesses have performed well despite disruption
in Myanmar from the impact of the Covid-19 virus during 2020:
-- AP Towers: the Company swapped its interest in Apollo Towers
for an interest in AP Towers in January 2020. The share exchange
effectively brought Apollo Towers and Pan Asia Towers, another ITC
under the common ownership of AP Towers which now manages one of
the largest network of towers in Myanmar; and
-- MFIL: with additional equity investment and additional debt
facilities in place the business has grown well in size, product
mix and geographic reach. This growth has however been tempered by
an increase in non-performing loans which, pre-Covid-19, had risen
to around 1.9% due to borrower over-indebtedness and excessive
competition. In April 2020, we announced the agreement by ourselves
and our partners to sell 100% of this business to a Thai based
company but the completion of this transaction has been delayed by
the suspension of international flights to and from Myanmar which
has prevented the completion of our application for regulatory
approval.
Covid-19 has led to two lockdowns but MFIL, having taken quick
action, emerged at the end of September with PAR 30+ at 3.1 per
cent. However, it is too early to forecast how the industry will
emerge in January 2021 from the FRD's collection suspension
directive.
In all cases, Myanmar Investment's team have worked closely with
these businesses to provide strategic advice as well as hands-on
local knowledge.
Financial Review
NET ASSET VALUE
The Directors assess the Group's NAV attributable to the
shareholders of the Company as at 30 September 2020 to be US$35.3
million, an increase of 6.0 per cent compared with the Group's NAV
as at 31 March 2019. This represents US$0.93 per share, based on
the number of shares in issue at the year-end. This change
principally reflects the net changes in the Directors' assessment
of the values of the Company's investments, described in more
detail below, less the Group's running costs for the year.
As at 30 September 2020 the Group's NAV consisted of:
-- an investment in AP Towers, the telecommunication tower
business, of US$28.3 million, excluding the non-controlling
interests, determined using a comparable EBITDA multiple
methodology;
-- an investment in MFIL, the microfinance business, of US$4.4
million, determined using a price to book value methodology;
and
-- cash and other net assets/liabilities of US$2.6 million.
AP TOWERS / APOLLO TOWERS
As at 31 March 2019 the Directors had assessed that if the share
exchange had been completed by 31 March 2019, the Company's
attributable shareholding in AP Towers , excluding the
non-controlling interests attributable to the minority shareholders
of MIL 4, would have been worth US$30 million as at that date,
using a comparable EBITDA multiple methodology .
The share exchange was completed in January 2020.
Using the same methodology as at 30 September 2020, the
Directors have assessed the value of this investment to be US$28.3
million. The downward revision in valuation of US$1.7 million
compared with the in-principle valuation of the AP Towers
investments done in 31 March 2019, is mainly attributable to the
increase in EBITDA over the period being offset by a decrease in
the valuation multiple.
This value of AP Towers represents an unrealised gain of US $7.5
million over the cost of the investment and an
IRR since the initial investment in July 2015 of 6.2 per cent.
MFIL
As at 31 March 2019 the Directors had assessed the value of the
Group's investment in MFIL to be US$4.4 million, using the price to
book value methodology.
However, unlike in previous reports, given that we have received
a firm offer for the company we have applied the offer's multiple
but with a discount to reflect trading conditions for the valuation
as at 30 September 2020.
Therefore, the Directors have assessed the value of this
investment to still be US$4.4 million as at 30 September 2020.
This value of MFIL represents an unrealised gain of US $1.7
million over the cost of the investment . This equates to an IRR
since the initial investment in September 2014 of 10.7 per
cent.
MEDICARE
Given the Company's strategy of looking to realise its
investments, coupled with Medicare's continued operating losses
that needed funding as well as the capex needed to get Medicare to
achieve critical mass, the Directors concluded that it was
preferable to exit from this investment sooner rather than
later.
As a result, the Company agreed with the owners of Medicare
Vietnam, its main joint venture partner, to sell this investment
for US$1 million in November 2019. This represented a loss of
US$1.1 million on the cost of the investment which largely reflects
MIL's share of the operating losses to date. The Company had booked
US$1.5 million as its share of results of this joint venture
(equity method). Therefore, the sales price of US$1 million
represents a gain on the disposal of this investment of US$0.4
million.
As at 31 March 2019 this investment had been valued by the
Directors at US$1.2 million.
SUMMARY OF NAV
In the attached audited financial statements, the NAV
attributable to shareholders differs from the above stated value of
US$35.3 million due to the following adjustment:
US$ millions
NAV per the audited financial statements 33.4
MFIL (Note 1) 1.9
NAV per the Directors' valuation 35.3
Note 1: In accordance with IFRS 11 Joint Arrangements, the
investment in MFIL was accounted for as an investment in a joint
venture (as the result of the ongoing transaction to sell the
Group's 37.5% equity interest in MFIL, the entire carrying amount
of the Group's investment in MFIL has been reclassified as
non-current asset held for sale as at 30 September 2020) using the
equity method. Whereas in accordance with the Group's Valuation
Policy the Directors' valuation for MFIL is determined by reference
to the International Private Equity and Venture Capital
Guidelines.
FINANCIAL RESULTS
For the 18-month period to 30 September 2020 the Group's audited
profit after tax was US$1.6 million. Compared with the 12-month
period to 31 March 2019 the Group's audited loss after tax was
US$2.4 million.
This is a significant improvement on last year's result. The
profit per share is US cents 4.24 compared with a loss per share of
US cents 6.42 for the 12-month period to 31 March 2019.
We have continued to streamline our operations and as a result
reduced our overheads with most of the reductions coming towards
the end of this reporting period. As part of the cost reduction
process, we closed our office in Yangon and laid-off our local
staff as of 31 March 2020. The annualised core cash-based overheads
(including the costs of being a quoted company but excluding
discretionary compensation, share option expenses and transaction
costs) for the 6-month period from 1 April 2020 to 30 September
2020 ( US$0.7 million) are 43 % lower than for the 12-month period
from 1 April 2019 to 31 March 2020 ( US$1.3 million) and even 55 %
lower than for the 12-month period from 1 April 2018 to 31 March
2019 ( US$1.6 million) .
Outside of our overheads the most significant items were:
-- our share of Medicare's losses up to the date that we sold it
which were US$576,000 compared to last year's US$603,000;
-- our share of MFIL's losses which were US$350,000 compared to
last year's profits of US$112,000;
-- costs for sale of our investments and the legal fees for the
share swap from Apollo Towers to AP Towers.
CHANGE OF YEAR
The Myanmar Government had announced that all Myanmar companies
must change their financial year end to 30 September of each year,
commencing in 2019. As such all of the Company's investee companies
changed their year end and therefore the Company did the same.
Therefore, the Company issued interim accounts for the six
months to 30 September 2019 (announced on 28 November 2019) and
also for the six months to 31 March 2020 (announced on 29 June
2020). The two sets of interim accounts were reviewed by BDO LLP,
the Company's statutory auditors.
As a consequence, this report with a full audited set of
financial statements comprises the 18-month period from 1 April
2019 (the last full audited set of financial statements) to 30
September 2020.
DIVIDS
Based on the above the Directors do not recommend payment of a
dividend at this time.
WORKING CAPITAL
Based as of the date of this report the Group has adequate
financial resources to cover its working capital needs for the next
12 months.
NICK PARIS
Managing Director
27 November 2020
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
FOR THE FINANCIAL PERIOD FROM 1 APRIL 2019 TO 30 SEPTEMBER
2020
Financial
period from
1 April 2019 Financial
to year ended
30 September 31 March
Note 2020 2019
US$ US$
Revenue - -
Other item of income
Finance income 4 491 514
Gain on disposal of a joint venture 10 361,248 -
Fair value gain on investment at fair
value through profit or loss 11 6,500,000 -
Items of expense
Employee benefits expense 5 (898,323) (916,343)
Depreciation expense 12 (20,719) (22,001)
Other operating expenses (1,325,262) (1,006,933)
Finance costs 6 (13,857) (12,715)
Share of results of joint ventures,
net of tax 10 (926,004) (491,290)
Profit/(Loss) before income tax 7 3,677,574 (2,448,768)
Income tax expense 8 (1,306) (436)
Profit/(Loss) for the financial period/year 3,676,268 (2,449,204)
============= ===========
Other comprehensive income:
Items that may be reclassified subsequently
to profit or loss:
Exchange gain/(loss) arising on translation
of foreign
operations 10 399,314 (263,584)
Other comprehensive income for the
financial period/year, net of tax 399,314 (263,584)
------------- -----------
Total comprehensive income/(loss) for
the financial period/year 4,075,582 (2,712,788)
============= ===========
Profit/(Loss) attributable to:
Owners of the parent 1,616,159 (2,420,931)
Non-controlling interests 13 2,060,109 (28,273)
------------- -----------
3,676,268 (2,449,204)
============= ===========
Total comprehensive income/(loss) attributable
to:
Owners of the parent 2,015,473 (2,684,515)
Non-controlling interests 13 2,060,109 (28,273)
4,075,582 (2,712,788)
============= ===========
Earnings/(Loss) per share (cents)
* Basic and diluted 9 4.24 (6.42)
============= ===========
The accompanying notes form an integral part of these financial
statements.
CONSOLIDATED STATEMENT OF FINANCIAL POSITION AS AT 30 SEPTEMBER
2020
30 September 31 March
Note 2020 2019
US$ US$
ASSETS
Non-current assets
Investments in joint ventures 10 - 3,717,909
Equity instrument at fair value through
profit or loss 11 42,500,000 36,000,000
Plant and equipment 12 - 38,103
------------ ------------
Total non-current assets 42,500,000 39,756,012
------------ ------------
Current assets
Other receivables 14 268,834 178,775
Cash and cash equivalents 15 2,364,166 3,720,521
Non-current asset classified as held
for sale 16 2,552,467 -
------------ ------------
Total current assets 5,185,467 3,899,296
------------ ------------
Total assets 47,685,467 43,655,308
============ ============
EQUITY AND LIABILITIES
Equity
Share capital 17 40,569,059 40,569,059
Share option reserve 18 1,358,913 1,337,005
Accumulated losses (8,423,481) (10,039,640)
Foreign exchange reserve (76,560) (475,874)
Equity attributable to owners of the
parent 33,427,931 31,390,550
Non-controlling interests 13 13,935,567 11,875,458
------------ ------------
Total equity 47,363,498 43,266,008
------------ ------------
LIABILITIES
Current liabilities
Other payables 19 304,053 372,410
Income tax payable 17,916 16,890
------------ ------------
Total current liabilities 321,969 389,300
Total equity and liabilities 47,685,467 43,655,308
============ ============
The accompanying notes form an integral part of these financial
statements.
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
FOR THE FINANCIAL PERIOD FROM 1 APRIL 2019 TO 30 SEPTEMBER
2020
Equity
attributable
Share Foreign to owners Non-
Share option exchange Accumulated of controlling
Note capital reserve reserve losses the parent interests Total
US$ US$ US$ US$ US$ US$ US$
2020
At 1 April 2019 40,569,059 1,337,005 (475,874) (10,039,640) 31,390,550 11,875,458 43,266,008
Profit for the
financial period - - - 1,616,159 1,616,159 2,060,109 3,676,268
Other comprehensive
income for
the financial period
Exchange loss arising
on translation
of foreign operations 10 - - 399,314 - 399,314 - 399,314
Total other
comprehensive income
for the financial
period - - 399,314 - 399,314 - 399,314
---------- --------- --------- ------------ ------------- ------------
Total comprehensive
income for
the financial period - - 399,314 1,616,159 2,015,473 2,060,109 4,075,582
Contributions by and
distributions
to owners
---------- --------- --------- ------------ ------------- ------------ ----------
Share options expense 18 - 21,908 - - 21,908 - 21,908
Total contributions by
and distributions
to owners - 21,908 - - 21,908 - 21,908
At 30 September 2020 40,569,059 1,358,913 (76,560) (8,423,481) 33,427,931 13,935,567 47,363,498
========== ========= ========= ============ ============= ============ ==========
The accompanying notes form an integral part of these financial
statements.
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
FOR THE FINANCIAL PERIOD FROM 1 APRIL 2019 TO 30 SEPTEMBER
2020
Equity
attributable
Share Foreign to owners Non-
Share option exchange Accumulated of controlling
Note capital reserve reserve losses the parent interests Total
US$ US$ US$ US$ US$ US$ US$
2019
At 1 April 2018 40,161,942 1,220,549 (212,290) (7,641,751) 33,528,450 11,903,731 45,432,181
Loss for the financial
year - - - (2,420,931) (2,420,931) (28,273) (2,449,204)
Other comprehensive
loss for the
financial year
Exchange loss arising
on translation
of foreign operations 10 - - (263,584) - (263,584) - (263,584)
Total other
comprehensive loss
for the financial
year - - (263,584) - (263,584) - (263,584)
---------- --------- --------- ------------ ------------- ------------
Total comprehensive
loss for the
financial year - - (263,584) (2,420,931) (2,684,515) (28,273) (2,712,788)
Contributions by and
distributions
to owners
---------- --------- --------- ------------ ------------- ------------ -----------
Exercise of warrants 17 491,916 - - - 491,916 - 491,916
Share issue expenses 17 (84,799) - - - (84,799) - (84,799)
Share options expense 18 - 139,498 - - 139,498 - 139,498
Cancellation of share
options 18 - (23,042) - 23,042 - - -
Total contributions by
and distributions
to owners 407,117 116,456 - 23,042 546,615 - 546,615
At 31 March 2019 40,569,059 1,337,005 (475,874) (10,039,640) 31,390,550 11,875,458 43,266,008
========== ========= ========= ============ ============= ============ ===========
The accompanying notes form an integral part of these financial
statements.
CONSOLIDATED STATEMENT OF CASH FLOWS
FOR THE FINANCIAL PERIOD FROM 1 APRIL 2019 TO 30 SEPTEMBER
2020
Financial
period from
1 April 2019 Financial
to year ended
30 September 31 March
Note 2020 2019
US$ US$
Operating activities
Profit/(Loss) before income tax 3,677,574 (2,448,768)
Adjustments for:
Interest income 4 (491) (514)
Finance costs 6 13,857 12,715
Depreciation of plant and equipment 12 20,719 22,001
Gain on disposal of a joint venture 10 (361,248) -
Fixed assets written off 7 17,384 -
Fair value gain on investment at fair
value through profit
or loss 11 (6,500,000) -
Share options expense 18 21,908 139,498
Share of results of joint ventures,
net of tax 10 926,004 491,290
Operating cash flows before working
capital changes (2,184,293) (1,783,778)
Changes in working capital:
Other receivables (90,059) 15,809
Other payables (68,357) (59,920)
Cash used in operations (2,342,709) (1,827,889)
Interest received 4 491 514
Finance costs paid 6 (13,857) (12,715)
Income tax (paid)/refund (280) 1,517
Net cash flows used in operating activities (2,356,355) (1,838,573)
------------- -----------
Investing activities
Proceeds from disposal of investments 10 1,000,000 -
Investments in joint ventures 10 - (500,000)
Advances to joint ventures 10 - (625,000)
Purchase of plant and equipment 12 - (5,353)
------------- -----------
Net cash flows generated from/(used
in) investing activities 1,000,000 (1,130,353)
Financing activities
Increase in short-term deposits pledged (216) (11,267)
Net proceeds from issuance of shares 17 - 407,117
------------- -----------
Net cash flows (used in)/generated
from financing activities (216) 395,850
Net change in cash and cash equivalents (1,356,571) (2,573,076)
Cash and cash equivalents at beginning
of the period/year 3,673,110 6,246,186
Cash and cash equivalents at the end
of financial period/year 15 2,316,539 3,673,110
============= ===========
The accompanying notes form an integral part of these financial
statements.
NOTES TO THE FINANCIAL STATEMENTS
FOR THE FINANCIAL PERIOD FROM 1 APRIL 2019 TO 30 SEPTEMBER
2020
1. General corporate information
Myanmar Investments International Limited ("the Company") is a
limited liability company incorporated and domiciled in the British
Virgin Islands ("BVI"). The Company's registered office is at Jayla
Place, Wickhams Cay I, Road Town, Tortola, British Virgin
Islands.
The Company's ordinary shares and warrants are traded on the AIM
market of the London Stock Exchange under the ticker symbols MIL
and MILW respectively.
The Company was established for the purpose of identifying and
investing in, and disposing of, businesses operating in or with
business exposure to Myanmar. The Company's focus was to target
businesses operating in sectors that the Directors believed had
strong growth potential and thereby could be expected to provide
attractive yields, capital gains or both. At the Annual General
Meeting held on 24 October 2019, the Company's shareholders
approved a resolution to begin an orderly disposal of the Company's
investments and in due course look to return surplus capital to
shareholders.
The principal activities of the subsidiaries are disclosed in
Note 13 to the financial statements.
The Group and the Company changed its reporting period end from
31 March to 30 September during the current financial period.
1.1 Going concern
After due and careful enquiries, the Directors have a reasonable
expectation that the Group has adequate financial resources to
continue in operational existence for the foreseeable future. This
expectation is based on a review of the Group's existing financial
resources, its present and expected future commitments in terms of
its overheads and running costs; and its commitments to its
existing investments. Accordingly, the Directors have adopted the
going concern basis in preparing the Group's financial
statements.
2. Summary of significant accounting policies
The Company's significant accounting judgements and estimates
used in the preparation of these financial statements are available
in the full audited financial statements, a copy of which can be
found on the Company's website at www.myanmarinvestments.com.
NOTES TO THE FINANCIAL STATEMENTS
FOR THE FINANCIAL PERIOD FROM 1 APRIL 2019 TO 30 SEPTEMBER
2020
3. Significant accounting judgements and estimates
The preparation of the Group's financial statements requires
management to make judgements, estimates and assumptions that
affect the reported amounts of revenues, expenses, assets and
liabilities and the accompanying disclosures, and the disclosure of
contingent liabilities at the reporting date. Uncertainty about
these assumptions and estimates could result in outcomes that could
require a material adjustment to the carrying amount of the asset
or liability affected in the future periods.
3.1 Critical judgements made in applying the entity's accounting policies
In the process of applying the Group's accounting policies,
management is of the opinion that there are no critical judgements
involved that have a significant effect on the amounts recognised
in the financial statements.
3.2 Key sources of estimation uncertainty
The key assumptions concerning the future and other key sources
of estimation uncertainty at the reporting date, that have a
significant risk of causing a material adjustment to the carrying
amounts of assets and liabilities within the next financial year,
are described below. The Group based its assumptions and estimates
on parameters available when the financial statements were
prepared. Existing circumstances and assumptions about future
developments, however, may change due to market changes or
circumstances arising beyond the control of the Group. Such changes
are reflected in the assumptions when they occur.
(i) Fair value of unquoted equity instrument at fair value through profit or loss
The Group's equity instrument at fair value through profit or
loss are measured at fair value for financial reporting purposes.
The Board of Directors of the Company has set up an Investment
Committee to determine the appropriate valuation techniques and
inputs for fair value measurements being the EV/EBITDA
multiple.
In estimating the fair value of an asset or a liability, the
Group uses market-observable data to the extent it is available.
Where Level 1 inputs are not available, the Group engages internal
qualified valuers to perform the valuation. The Investment
Committee works closely with the qualified internal valuers to
establish the appropriate valuation techniques and inputs to the
model. The Investment Committee reports its findings to the Board
of Directors of the Company on a periodic basis to explain the
cause of fluctuations in the fair value of the assets and
liabilities.
Information about the valuation techniques and inputs used in
determining the fair value of the unquoted equity instrument at
fair value through profit or loss are disclosed in Note 11 to the
financial statements.
(ii) Impairment of investments in joint ventures
The Group follows the guidance of IAS 36 in determining whether
investments in joint ventures are impaired. This determination
requires significant judgement. The Group evaluates, among other
factors, the duration and extent to which the recoverable amounts
of investments in joint ventures are less than their carrying
amounts and the financial health of and near-term business outlook
for investments in joint ventures, including factors such as
industry and sector performance, changes in technology and
operational and financing cash flows. The carrying amounts of
investments in joint ventures before classification as non-current
asset held for sale are disclosed in Note 10 to the financial
statements.
NOTES TO THE FINANCIAL STATEMENTS
FOR THE FINANCIAL PERIOD FROM 1 APRIL 2019 TO 30 SEPTEMBER
2020
3. Significant accounting judgements and estimates
3.2 Key sources of estimation uncertainty (Continued)
(iii) Employee share option plan
The Group measures the cost of equity-settled transactions with
employees by reference to the fair value of the equity instruments
at the date at which they are granted. Estimating fair value for
share-based payment transactions requires determining the most
appropriate valuation model, which is dependent on the terms and
conditions of the grant. This estimate also requires determining
the most appropriate inputs to the valuation model including
expected life of the share option, volatility and dividend yield
and making assumptions about them. The carrying amount and
assumptions and model for estimating fair value for share-based
payment transactions are set out in Note 18 to the financial
statements.
4. Finance income
Financial
period from
1 April 2019 Financial
to year ended
30 September 31 March
2020 2019
US$ US$
Interest income 491 514
============= ===========
5. Employee benefits expense
Financial
period from
1 April 2019 Financial
to year ended
30 September 31 March
2020 2019
US$ US$
Salaries, wages and other staff benefits 826,415 739,024
Bonuses 50,000 37,821
Share options expense (Note 18) 21,908 139,498
------------- -----------
898,323 916,343
============= ===========
The employee benefits expense includes the remuneration of
Directors as disclosed in Note 20 to the financial statements.
6. Finance costs
Finance costs represent bank charges for the financial
period/year.
NOTES TO THE FINANCIAL STATEMENTS
FOR THE FINANCIAL PERIOD FROM 1 APRIL 2019 TO 30 SEPTEMBER
2020
7. Profit/(Loss) before income tax
In addition to the charges and credits disclosed elsewhere in
the notes to the financial statements, the above includes the
following charges:
Financial
period from
1 April 2019 Financial
to year ended
30 September 31 March
2020 2019
US$ US$
Auditor's remuneration 103,397 61,278
Consultants fees 218,999 268,564
Fixed assets written off 17,384 -
Operating lease expenses - 91,381
Short term leases 84,206 -
Professional fees 599,324 287,288
Travel and accommodation 54,572 59,769
============= ===========
8. Income tax expense
Financial
period from
1 April 2019 Financial
to year ended
30 September 31 March
2020 2019
US$ US$
Current income tax
* current financial period/year 3,703 1,574
* over-provision in prior financial year (2,397) (1,138)
------------- -----------
1,306 436
============= ===========
A reconciliation of income tax applicable to profit/(loss)
before income tax at the statutory income tax rate of 25% (2019:
25%) in Myanmar is as follows:
Financial
period from
1 April 2019 Financial
to year ended
30 September 31 March
2020 2019
US$ US$
Profit/(Loss) before income tax 3,677,574 (2,448,768)
Share of results of joint venture, net of
tax (Note 10) 926,004 491,290
------------- -----------
4,603,578 (1,957,478)
------------- -----------
NOTES TO THE FINANCIAL STATEMENTS
FOR THE FINANCIAL PERIOD FROM 1 APRIL 2019 TO 30 SEPTEMBER
2020
8. Income tax expense (Continued)
Financial
period from
1 April
2019 Financial
to year ended
30 September 31 March
2020 2019
Income tax at the applicable tax rates 1,150,895 (489,370)
Effects of different income tax rates in
other countries (1,151,928) 489,905
Over-provision in prior financial year (2,397) (1,138)
Tax effects of expenses not deductible for
tax purposes 5,741 1,039
Income tax exemption (1,005) -
Income tax for the financial period/year 1,306 436
============== ============
A.
9. Earnings/(Loss) per share
Basic earnings or loss per share is calculated by dividing the
profit or loss for the financial period/year attributable to owners
of the parent by the weighted average number of ordinary shares
outstanding during the financial period/year.
The following reflects the profit or loss and share data used in
the basic and diluted earnings or loss per share computation:
Financial
period from
1 April 2019 Financial
to year ended
30 September 31 March
2020 2019
Profit/(Loss) for the financial period/year
attributable to owners of the Company (US$) 1,616,159 (2,420,931)
Weighted average number of ordinary shares
during
the financial period/year applicable to
basic profit
or loss per share 38,097,037 37,685,988
Earnings/(Loss) per share
Basic and diluted (cents) 4.24 (6.42)
============= ===========
Diluted earnings or loss per share is the same as the basic
earnings or loss per share because the potential ordinary shares to
be converted arising from share options and warrants are
anti-dilutive.
NOTES TO THE FINANCIAL STATEMENTS
FOR THE FINANCIAL PERIOD FROM 1 APRIL 2019 TO 30 SEPTEMBER
2020
10. Investments in joint ventures
30 September 31 March
2020 2019
US$ US$
Investments in joint ventures
Unquoted equity investments, at cost 4,815,000 4,190,000
Share of post-acquisition results of joint
venture, net of tax (1,547,221) (621,217)
Share of post-acquisition foreign currency
translation reserve (76,560) (475,874)
3,191,219 3,092,909
Disposal of joint venture during the financial
period/year (638,752) -
Advances to joint ventures - 625,000
Reclassified to non-current asset held-for-sale (2,552,467) -
------------ ---------
- 3,717,909
============ =========
Movement during the period/year
Balance at beginning of financial period/year 3,717,909 3,347,783
Investments during the financial period/year - 500,000
Share of results of joint ventures, net
of tax (926,004) (491,290)
Share of foreign currency translation reserve 399,314 (263,584)
Advances during the financial period/year - 625,000
Disposal of joint venture during the financial
period/year (638,752) -
Reclassified to non-current asset held-for-sale (2,552,467) -
----------- ---------
Balance at end of financial period/year - 3,717,909
=========== =========
Medicare International Health and Beauty Pte. Ltd. and its
subsidiary ("MIHB Group")
On 28 November 2019, the Group disposed its entire investment in
MIHB Group for US$1,000,000. For the period from 1 April 2019 to 28
November 2019 (date of disposal), the Group recorded share of
losses from its investment in MIHB Group amounting to US$576,305.
The carrying amount of the Group's investment in MIHB Group as at
the date of disposal was US$638,752. As a result, the Group
recognised a gain on disposal of US$361,248.
Myanmar Finance International Ltd.
In the previous financial year, MFIL issued 1,000,000 shares for
a consideration of US$1,000,000 for which the Group subscribed for
375,000 shares and MFIL capitalised the previous year's advance of
US$375,000.
MFIL is a well-established provider of microfinance loans to
small-scale business operators in rural and urban areas of Yangon,
Bago and Mon State.
MFIL is deemed to be a joint venture of the Group as the
appointment of its directors and the allocation of voting rights
for key business decisions require the unanimous approval of all
its shareholders.
NOTES TO THE FINANCIAL STATEMENTS
FOR THE FINANCIAL PERIOD FROM 1 APRIL 2019 TO 30 SEPTEMBER
2020
10. Investments in joint ventures (Continued)
The details of the joint ventures are as follows:
Name of joint ventures Effective
(Country of incorporation/ equity interest
place of business) Principal activities held by the Group
2020 2019
% %
Medicare International Health Provider of beauty,
and Beauty Pte. Ltd. health, and pharmaceutical
(Singapore) products - 48. 6
Myanmar Finance International
Limited Provider of microfinance
(Myanmar) loans - 37.5
On 26 February 2020, MIL together with each of the other
shareholders of MFIL, have received a Binding Offer ("BO") to sell
the entire share capital of MFIL to Thitikorn Plc ("TK") (the
"Purchaser"), a consumer finance company incorporated in Thailand
and listed on the Stock Exchange of Thailand.
The original BO was executed on 17 March 2020 with the intention
of agreeing and executing the Sale and Purchase Agreement ("SPA")
within a month. However, due to the outbreak of Covid-19, the
regulatory approval could not be obtained in time. Therefore, the
BO has been extended for several times and the latest BO has been
extended to 5 December 2020. Management expects it to further
extend to early 2021.
In accordance with the BO, the minimum consideration for this
transaction will be calculated based on a pre-agreed formula of 2
times the audited book value of MFIL at closing once conditions
above have been satisfied.
As the result of the ongoing transaction above, the entire
carrying amount of the Group's investment in MFIL has been
reclassified as non-current asset held for sale as at 30 September
2020 (Note 16).
NOTES TO THE FINANCIAL STATEMENTS
FOR THE FINANCIAL PERIOD FROM 1 APRIL 2019 TO 30 SEPTEMBER
2020
11. Equity instrument at fair value through profit or loss
30 September 31 March
2020 2019
US$ US$
Investment in unquoted equity instrument,
at fair value 42,500,000 36,000,000
============ ==========
The Group, through its 66.67% subsidiary, MIL 4 Limited ("MIL
4") invested in a 6.2% equity interest in unquoted share capital of
AP Towers Holdings Pte. Ltd. ("AP Towers") (31 March 2019: 13.7%
equity interest in Apollo Towers Holdings Limited ("Apollo
Towers")).
On 23 January 2020, MIL 4 exchanged its investment in Apollo
Towers for shares in AP Towers which owns Pan Asia Majestic Eagle
Limited ("Pan Asia Towers"), another Myanmar independent tower
company. Under the share swap, MIL 4 has exchanged its existing
13.7 per cent shareholding in Apollo Towers for a shareholding of
6.2 per cent in AP Towers. The share swap effectively brings Apollo
Towers and Pan Asia Towers under common ownership of AP Towers.
Movement in the investment in unquoted equity instrument is as
follows:
30 September 31 March
2020 2019
US$ US$
Balance at beginning of financial period/year 36,000,000 36,000,000
Fair value gain during the financial period/year 6,500,000 -
Balance at end of financial period/year 42,500,000 36,000,000
============ ==========
The Group intends to hold these investments for long-term
appreciation in value as well as strategic investment purposes.
Management engaged their internal valuation specialists to
perform a valuation on the investment. The valuation of the
unquoted investment is categorised into Level 3 (2019: Level 3) of
the fair value hierarchy. The information on the significant
unobservable inputs and the inter-relationship between key
unobservable inputs and fair value are as follows:
30 September 2020
Inter-relationship
between key
Valuation unobservable
Financial technique Significant inputs
assets used unobservable inputs and fair value
Unquoted Comparable Increase EBITDA
equity company * Earnings Before Interest, Tax, Depreciation and and EV/EBITDA
investments analysis Amortisation ("EBITDA") of US$83.4million multiple
will increase
the
fair value of
* Enterprise Value ("EV") per EBITDA multiple of 13.1x the
financial asset.
NOTES TO THE FINANCIAL STATEMENTS
FOR THE FINANCIAL PERIOD FROM 1 APRIL 2019 TO 30 SEPTEMBER
2020
11. Equity instrument at fair value through profit or loss (Continued)
31 March 2019
Inter-relationship
between key
Valuation unobservable
Financial technique Significant inputs
assets used unobservable inputs and fair value
Unquoted Comparable Increase EBITDA
equity company * Earnings Before Interest, Tax, Depreciation and and EV/EBITDA
investments analysis Amortisation ("EBITDA") of US$32.2million multiple
will increase
the
fair value of
* Enterprise Value ("EV") per EBITDA multiple of 15.4x the
financial asset.
12. Plant and equipment
Computer Furniture
equipment Office equipment and fittings Total
US$ US$ US$ US$
2020
Cost
Balance at 1 April 2019 10,852 1,118 56,469 68,439
Written off (10,852) (1,118) (56,469) (68,439)
Balance at 30 September 2020 - - - -
========== ================ ============= ========
Accumulated depreciation
Balance at 1 April 2019 6,865 1,118 22,353 30,336
Depreciation for the financial
period 2,326 - 18,393 20,719
Written off (9,191) (1,118) (40,746) (51,055)
Balance at 30 September 2020 - - - -
========== ================ ============= ========
Carrying amount
Balance at 30 September 2020 - - - -
========== ================ ============= ========
NOTES TO THE FINANCIAL STATEMENTS
FOR THE FINANCIAL PERIOD FROM 1 APRIL 2019 TO 30 SEPTEMBER
2020
12. Plant and equipment (Continued)
Computer Furniture
equipment Office equipment and fittings Total
US$ US$ US$ US$
2019
Cost
Balance at 1 April 2018 9,983 1,118 51,985 63,086
Additions 869 - 4,484 5,353
Balance at 31 March 2019 10,852 1,118 56,469 68,439
========== ================ ============= ======
Accumulated depreciation
Balance at 1 April 2018 3,472 796 4,067 8,335
Depreciation for the financial
year 3,393 322 18,286 22,001
Balance at 31 March 2019 6,865 1,118 22,353 30,336
========== ================ ============= ======
Carrying amount
Balance at 31 March 2019 3,987 - 34,116 38,103
========== ================ ============= ======
13. Investment in subsidiaries
Details of the subsidiaries are as follows:
Proportion Proportion
of of
Country of ownership ownership
incorporation/ interest interest
principal held by the held by non-control
Name of subsidiaries place of business Principal activities Group interests
2020 2019 2020 2019
% % % %
Myanmar Investments Investment holding
Limited(1) Singapore company 100 100 - -
Provision of
MIL Management Pte. management services
Ltd.(1) Singapore to the Group 100 100 - -
British
Virgin Investment holding
MIL 4 Limited(1) Islands company 66.67 66.67 33.33 33.33
Held by MIL Management
Pte. Ltd.
Provision of
MIL Management Co., management services
Ltd(2) Myanmar to the Group 100 100 - -
(1) Audited by BDO LLP, Singapore.
(2) In the process of striking off.
NOTES TO THE FINANCIAL STATEMENTS
FOR THE FINANCIAL PERIOD FROM 1 APRIL 2019 TO 30 SEPTEMBER
2020
13. Investment in subsidiaries (Continued)
Non-controlling interests
The summarised financial information before intra-group
elimination of the subsidiary that has material non-controlling
interests as at the end of each reporting period is as follows:
MIL 4 Limited
30 September 31 March
2020 2019
US$ US$
Assets and liabilities
Non-current assets 42,500,000 36,000,000
Current assets 71,067 72,896
Current liabilities (764,373) (446,529)
Net assets 41,806,694 35,626,367
================== =============
Accumulated non-controlling interests 13,935,567 11,875,458
================== =============
Revenue - -
Other income 6,500,000 -
Administrative expenses (319,673) (84,822)
------------------ -------------
Profit/(Loss) and total comprehensive income/(loss)
for the financial period/year 6,180,327 (84,822)
Profit/(Loss) and total comprehensive income/(loss)
allocated to non-controlling interests 2,060,109 (28,273)
================== =============
Operating cash flows before working capital
changes (319,673) (84,822)
Working capital changes 319,673 84,822
------------------ -------------
Net cash used in operating activities - -
------------------ -------------
Net change in cash and cash equivalents - -
================== =============
14. Other receivables
30 September 31 March
2020 2019
US$ US$
Other receivables 211,962 123,099
Deposits 9,061 23,310
Prepayments 47,811 32,366
------------ --------
268,834 178,775
============ ========
Other receivables are denominated in United States dollar.
NOTES TO THE FINANCIAL STATEMENTS
FOR THE FINANCIAL PERIOD FROM 1 APRIL 2019 TO 30 SEPTEMBER
2020
15. Cash and cash equivalents
30 September 31 March
2020 2019
US$ US$
Cash and bank balances 2,316,539 3,673,110
Short-term deposit 47,627 47,411
------------ ---------
2,364,166 3,720,521
============ =========
The short-term deposit bears interest at an average rate of
between 0.95% to 1.40% (31 March 2019: 0.35% to 0.95%) per annum,
has a tenure of approximately 12 months (31 March 2019: 12 months)
and is pledged to bank to secure credit facilities.
Cash and cash equivalents are denominated in the following
currencies:
30 September 31 March
2020 2019
US$ US$
United States dollar 2,232,114 3,562,238
Singapore dollar 129,031 148,419
Myanmar kyat 3,021 9,864
------------ ---------
2,364,166 3,720,521
============ =========
For the purpose of the statement of cash flows, cash and cash
equivalents comprise the following at the end of the financial
period/year:
30 September 31 March
2020 2019
US$ US$
Bank balances 2,364,166 3,720,521
Less: short-term deposits pledged (47,627) (47,411)
------------ ---------
2,316,539 3,673,110
============ =========
16. Non-current asset classified as held for sale
As the result of the ongoing transaction to sell the Group's
37.5% equity interest in MFIL (Note 10), the entire carrying amount
of the Group's investment in MFIL has been reclassified as
non-current asset held for sale as at 30 September 2020.
Details of assets in non-current asset classified as
held-for-sale are as follows:
At 30 September
2020
US$
Investment in joint venture - 37.5% equity interest
in Myanmar Finance International Limited 2,552,467
===============
NOTES TO THE FINANCIAL STATEMENTS
FOR THE FINANCIAL PERIOD FROM 1 APRIL 2019 TO 30 SEPTEMBER
2020
17. Share capital
30 September 31 March
2020 2019
US$ US$
Issued and fully-paid share capital:
Ordinary shares at the beginning of the financial
period/ year 40,569,059 40,161,942
Exercise of warrants during the financial period/year - 491,916
Share issuance expenses - (84,799)
------------
40,569,059 40,569,059
============ ==========
2020 2019
Ordinary Ordinary
Equity Instruments in issue shares Warrants shares Warrants
At the beginning of the
financial period/year 38,097,037 14,128,387 37,432,291 15,346,507
Exercise of warrants during
the financial period/year - - 664,746 (1,218,120)
---------- ---------- ---------- -----------
At the end of the financial
period/year 38,097,037 14,128,387 38,097,037 14,128,387
========== ========== ========== ===========
The holders of ordinary shares are entitled to receive dividends
as declared from time to time and are entitled to one vote per
share without restriction at meetings of the Company.
In the previous financial year, 202,905 and 377,486 warrants
were exercised at a price of US$0.75 and US$0.90 respectively by
the parties that held them for cash consideration of US$152,179 and
US$339,737. In addition, 637,729 warrants were exercised on a
cashless basis at a ratio of 7.56 warrants for an ordinary share
resulting in a new issue of 84,356 ordinary shares.
All the shares have been admitted to trading on AIM under the
ticker MIL.
The new ordinary shares issued in the previous financial year
ranked pari passu in all respects with the existing ordinary shares
of the Company.
NOTES TO THE FINANCIAL STATEMENTS
FOR THE FINANCIAL PERIOD FROM 1 APRIL 2019 TO 30 SEPTEMBER
2020
17. Share capital (Continued)
Warrants
No new warrants were issued during the period.
On 16 September 2016, the Company allotted 811,368 warrants
pursuant to the Fourth Subscription. The Company had agreed that
for every four Ordinary Shares subscribed for by a subscriber they
would receive one warrant at nil cost.
The warrants entitle the holder to subscribe for an Ordinary
share at an exercise price of US$0.75. The warrants may be
exercised during each 15 Business Day period commencing on the
first day of each Quarter during the Subscription Period (from 21
June 2015 to 21 June 2018).
On 22 May 2018, the Company amended the existing warrants to
extend the exercise period for warrants that remained outstanding
at 21 June 2018:
a) the exercise period for the warrants was extended such that
the warrants can be exercised until 31 December 2021, but at a
higher exercise price of US$0.90; and
b) in the extended period, warrantholders will have the option
to exercise their warrants on a cashless basis in certain
circumstances.
All warrants have been admitted to trading on AIM under the
ticker MILW.
18. Share option reserve
Details of the Share Option Plan (the "Plan")
The Plan has not changed during the year nor have any further
grants taken place. Full details can be found on the website at
www.myanmarinvestments.com.
19. Other payables
30 September 31 March
2020 2019
US$ US$
Accruals 113,294 287,262
Other payables 190,759 85,148
------------ --------
304,053 372,410
============ ========
NOTES TO THE FINANCIAL STATEMENTS
FOR THE FINANCIAL PERIOD FROM 1 APRIL 2019 TO 30 SEPTEMBER
2020
19. Other payables (Continued)
Other payables are denominated in the following currencies:
30 September 31 March
2020 2019
US$ US$
Singapore dollar 58,793 47,474
United States dollar 224,553 289,963
British pound 3,119 34,973
Euro 11,199 -
Myanmar Kyat 6,389 -
304,053 372,410
============ ========
20. Significant related party disclosures
For the purposes of these financial statements, parties are
considered to be related to the Group and the Company if the Group
and the Company have the ability, directly or indirectly, to
control the party or exercise significant influence over the party
in making financial and operating decisions, or vice versa, or
where the Group and the Company and the party are subject to common
control or common significant influence. Related parties may be
individuals or other entities. During the current financial period,
in addition to the information disclosed elsewhere in these
financial statements, there was no other significant transactions
with related parties.
NOTES TO THE FINANCIAL STATEMENTS
FOR THE FINANCIAL PERIOD FROM 1 APRIL 2019 TO 30 SEPTEMBER
2020
20. Significant related party disclosures (Continued)
Compensation of key management personnel
During the current financial period, no emoluments were paid by
the Group to the Directors as an inducement to join or upon joining
the Group or as compensation for loss of office.
The remuneration of Directors for the financial period/year were
as follows:
Short term Share
Directors' employee option
fee benefits plan Total
US$ US$ US$ US$
Financial period from 1 April
2019 to 30 September 2020
Executive directors
Maung Aung Htun - 192,823 5,115 197,938
Anthony Michael Dean - 267,209 5,115 272,324
Craig Robert Martin - 26,333 1,201 27,534
Nicholas John Paris 10,000 73,333 - 83,333
Non-executive
directors
Christopher
William Knight 24,789 - 1,201 25,990
Henrik Onne
Bodenstab 22,793 - 1,136 23,929
Rudolf Gildemeister 13,167 - - 13,167
----------
70,749 559,698 13,768 644,215
========== ========== ======= =======
Financial
year ended
31 March
2019
Executive
directors
Maung Aung
Htun - 141,156 41,038 182,194
Anthony Michael
Dean - 284,008 38,984 322,992
Craig Robert
Martin 7,500 58,250 8,629 74,379
Non-executive
directors
Christopher
William Knight 24,375 - 8,629 33,004
Christopher
David Appleton 12,333 - 5,752 18,085
Nicholas
John Paris 2,500 - - 2,500
Henrik Onne
Bodenstab 20,000 - 3,736 23,736
----------
66,708 483,414 106,768 656,890
========== ========== ======= =======
21. Dividends
The Directors of the Company do not recommend any dividend in
respect of the financial period from 1 April 2019 to 30 September
2020 (31 March 2019: Nil).
NOTES TO THE FINANCIAL STATEMENTS
FOR THE FINANCIAL PERIOD FROM 1 APRIL 2019 TO 30 SEPTEMBER
2020
22. Financial risk management objectives and policies
The Group's Financial risk management objectives and policies
have not changed in the past financial reporting period and can be
found on the website at www.myanmarinvestments.com.
23. Impact of novel coronavirus ("Covid-19") on the Group's operations
On 31 January 2020, the World Health Organisation ("WHO")
announced that the novel coronavirus ("Covid-19") outbreak as a
global health emergency.
The outbreak of Covid-19, coupled with the prolonged global
trade tension, had led to the deterioration of the global economic
conditions. The pandemic had already caused many industries to shut
down and trade and travel worldwide were seriously disrupted.
Although the situation continues to evolve with significant
level of uncertainty, the Group does not foresee a huge impact on
its own operation.
Regarding its investment in MFIL, the Group is of the view that
the microfinance industry has been impacted by Covid-19. Depending
on the speed of recovery from Covid-19, MFIL's book value at
closing of the on-going transaction to sell (Note 10) may decrease.
Shareholders of the Purchaser's has approved the transaction during
the annual general meeting held on 23 April 2020. However, because
of the outbreak of Covid-19 which, inter alia, has stopped all
commercial air travel between Myanmar and Thailand, little progress
has been made in obtaining regulatory approval. Assuming a level of
normalcy returns over the next few months, the completion of the
transaction is expected to take place within the next 4 to 6
months. Nonetheless, the Group is of the view that there is no
indicator of impairment on its investment in MFIL, because the
minimum consideration for this transaction will be calculated based
on a pre-agreed formula of 2 times the audited book value of MFIL
at closing once conditions above have been satisfied, according to
the Binding Offer from the Purchaser.
Regarding the Group's other investment in AP Towers, the Group
is of the view that contrary to other industries, the
telecommunication sector has not suffered greatly due to the
outbreak of Covid-19.
24. Authorisation of financial statements
The financial statements of the Group for the financial period
from 1 April 2019 to 30 September 2020 were approved by the Board
of Directors on 27 November 2020.
Notes to Editors
Myanmar Investments International Limited (AIM: MIL) was the
first Myanmar-focused investment company to be admitted to trading
on the AIM market of the London Stock Exchange. MIL was established
in 2013 with the intention of building long-term shareholder value
by proactively investing in a diversified portfolio of Myanmar
businesses that will benefit from the country's re-emergence and
ongoing economic development. The Company is led by an experienced
and entrepreneurial team who between them have considerable
industrial, corporate and financial management experience. At the
Annual General Meeting on 24 October 2019, the Company's
shareholders approved a change in the investment policy of the
Company to now seek to harvest the Company's investments over
time.
MIL's largest investment to-date at a cost of US$21 million is
in AP Towers, one of Myanmar's largest telecommunications towers
companies with approximately 3,245 towers. Apollo operates in the
high growth telecommunications sector with a strong management that
is growing the number of co-locations (i.e. multiple tenancies) on
its portfolio of towers. The re-financing Towers which is now
completed is expected to produce a more efficient and profitable
combined investment with greater prospects for an eventual
liquidity event for shareholders.
MIL's first investment in August 2014 was into Myanmar Finance
International Limited ("MFIL") which today is one of the leading
microfinance companies in Myanmar. Since MIL invested, MFIL's
business has expanded rapidly. The business is profitable with a
sustainable expansion plan for long-term growth. In November 2015,
the Norwegian Government's Norwegian Investment Fund for Developing
Countries ("Norfund"), the Norwegian development finance
institution, also became a 25 per cent shareholder in MFIL. MIL is
in the process of selling this investment. On 1 April 2020 MIL
announced that it has accepted an offer to sell its shareholding in
MFIL subject to the purchaser's AGM approving the purchase,
lender's consent, and Myanmar regulatory approval. Subsequent to
that announcement, the purchaser's AGM on 23(rd) April 2020 has
approved the transaction and the lenders have given their consent.
However, because of Covid-19 which, inter alia, has stopped all
commercial air travel between Myanmar and Thailand, little progress
has been made in obtaining regulatory approval. Assuming a level of
normalcy returns over the next few months we expect completion to
take place within the next 4 to 6 months.
On 28 November 2019, the Company announced that it had agreed to
dispose of its entire shareholding in Medicare International Health
& Beauty Pte. Ltd for US$1 million and this transaction
completed in December 2019.
Myanmar, a country of approximately 54 million people and
roughly the size of France, has been isolated for much of the last
50 years. Strategically situated in one of the world's most
economically dynamic regions amid the intersection of India, China
and South East Asia it is a key component of China's 'One Belt One
Road' strategy providing direct access to the Indian Ocean.
Whilst it was once one of the more prosperous countries in
Southeast Asia with an abundance of natural resources (oil, natural
gas, arable land, tourist attractions and a long coastline), it is
now one of the least developed countries in the world. However, it
has a number of competitive advantages: a population of 54 million
people (it is the 26th most populous country in the world); a large
workforce with a high literacy rate of 90 per cent; 68 per cent of
the population is of working age (between 15 and 65); and 28 per
cent of the population is under 24 which is expected to provide a
strengthening consumer demand. According to the IMF, Myanmar's GDP
growth rate is expected to be 6.8 per cent through to 2024.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
FR BDBDBRUDDGGC
(END) Dow Jones Newswires
November 30, 2020 02:00 ET (07:00 GMT)
Myanmar Investments (LSE:MIL)
Historical Stock Chart
From Nov 2024 to Dec 2024
Myanmar Investments (LSE:MIL)
Historical Stock Chart
From Dec 2023 to Dec 2024
